|
1
|
WHO: Hepatitis B Fact sheet July 2018.
http://www.who.int/mediacentre/factsheets/fs204/en/.
|
|
2
|
WHO: Hepatitis C Fact sheet July 2018.
http://www.who.int/mediacentre/factsheets/fs164/en/.
|
|
3
|
Umemura T, Ichijo T, Yoshizawa K, Tanaka E
and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan.
J Gastroenterol. 44 (Suppl 19):102–107. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Asahina Y, Tsuchiya K, Tamaki N, Hirayama
I, Tanaka T, Sato M, Yasui Y, Hosokawa T, Ueda K, Kuzuya T, et al:
Effect of aging on risk for hepatocellular carcinoma in chronic
hepatitis C virus infection. Hepatology. 52:518–527.
2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tanaka J, Koyama T, Mizui M, Uchida S,
Katayama K, Matsuo J, Akita T, Nakashima A, Miyakawa Y and
Yoshizawa H: Total numbers of undiagnosed carriers of hepatitis C
and B viruses in Japan estimated by age- and area-specific
prevalence on the national scale. Intervirology. 54:185–195.
2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tateishi R, Okanoue T, Fujiwara N, Okita
K, Kiyosawa K, Omata M, Kumada H, Hayashi N and Koike K: Clinical
characteristics, treatment, and prognosis of non-B, non-C
hepatocellular carcinoma: A large retrospective multicenter cohort
study. J Gastroenterol. 50:350–360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tateishi R, Uchino K, Fujiwara N, Takehara
T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura
T, et al: A nationwide survey on non-B, non-C hepatocellular
carcinoma in Japan: 2011-2015 update. J Gastroenterol. 54:367–376.
2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Al-Sharqi AJ: Periodontal status of
patients with hepatitis B viruses and B and C virus (comparative
study). J Pure Appl Microbiol. 12:293–300. 2018. View Article : Google Scholar
|
|
9
|
Nagao Y, Sata M, Tanikawa K, Itoh K and
Kameyama T: Lichen planus and hepatitis C virus in the northern
Kyushu region of Japan. Eur J Clin Invest. 25:910–914.
1995.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Nagao Y, Sata M, Tanikawa K, Itoh K and
Kameyama T: High prevalence of hepatitis C virus antibody and RNA
in patients with oral cancer. J Oral Pathol Med. 24:354–360.
1995.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Williams RC: Periodontal disease. N Engl J
Med. 322:373–382. 1990.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Socransky SS, Haffajee AD, Cugini MA,
Smith C and Kent RL Jr: Microbial complexes in subgingival plaque.
J Clin Periodontol. 25:134–144. 1998.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lamont RJ and Jenkinson HF: Life below the
gum line: Pathogenic mechanisms of Porphyromonas gingivalis.
Microbiol Mol Biol Rev. 62:1244–1263. 1998.PubMed/NCBI
|
|
14
|
Tonetti MS, Chapple IL, Jepsen S and Sanz
M: Primary and secondary prevention of periodontal and peri-implant
diseases: Introduction to, and objectives of the 11th European
Workshop on Periodontology consensus conference. J Clin
Periodontol. 42 (Suppl 16):S1–S4. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Falcao A and Bullón P: A review of the
influence of periodontal treatment in systemic diseases.
Periodontol 2000. 79:117–128. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bui FQ, Almeida-da-Silva CLC, Huynh B,
Trinh A, Liu J, Woodward J, Asadi H and Ojcius DM: Association
between periodontal pathogens and systemic disease. Biomed J.
42:27–35. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yoneda M, Naka S, Nakano K, Wada K, Endo
H, Mawatari H, Imajo K, Nomura R, Hokamura K, Ono M, et al:
Involvement of a periodontal pathogen, Porphyromonas
gingivalis on the pathogenesis of non-alcoholic fatty liver
disease. BMC Gastroenterol. 12(16)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Alazawi W, Bernabe E, Tai D, Janicki T,
Kemos P, Samsuddin S, Syn WK, Gillam D and Turner W: Periodontitis
is associated with significant hepatic fibrosis in patients with
non-alcoholic fatty liver disease. PLoS One.
12(e0185902)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nagao Y, Kawahigashi Y and Sata M:
Association of periodontal diseases and liver fibrosis in patients
with HCV and/or HBV infection. Hepat Mon. 14(e23264)2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yasui T, Tanaka S, Onozawa H, Matsumoto M,
Tanaka S and Nakao S: Mass screening of periodontal diseases using
new test paper for detecting salivary occult bold. Nippon Shika
Hyoron. 587:189–197. 1991.
|
|
21
|
Kaufman E and Lamster IB: Analysis of
saliva for periodontal diagnosis - a review. J Clin Periodontol.
27:453–465. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tada A, Takeuchi H, Shimizu H, Tadokoro K,
Tanaka K, Kawamura K, Yamaguchi T, Egashira T, Nomura Y and Hanada
N: Quantification of periodontopathic bacteria in saliva using the
invader assay. Jpn J Infect Dis. 65:415–423. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tadokoro K, Yamaguchi T, Kawamura K,
Shimizu H, Egashira T, Minabe M, Yoshino T and Oguchi H: Rapid
quantification of periodontitis-related bacteria using a novel
modification of Invader PLUS technologies. Microbiol Res.
165:43–49. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lee SC, Antony A, Lee N, Leibow J, Yang
JQ, Soviero S, Gutekunst K and Rosenstraus M: Improved version 2.0
qualitative and quantitative AMPLICOR reverse transcription-PCR
tests for hepatitis C virus RNA: Calibration to international
units, enhanced genotype reactivity, and performance
characteristics. J Clin Microbiol. 38:4171–4179. 2000.PubMed/NCBI
|
|
25
|
Sizmann D, Boeck C, Boelter J, Fischer D,
Miethke M, Nicolaus S, Zadak M and Babiel R: Fully automated
quantification of hepatitis C virus (HCV) RNA in human plasma and
human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin
Virol. 38:326–333. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dusheiko G, Schmilovitz-Weiss H, Brown D,
McOmish F, Yap PL, Sherlock S, McIntyre N and Simmonds P: Hepatitis
C virus genotypes: An investigation of type-specific differences in
geographic origin and disease. Hepatology. 19:13–18.
1994.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vallet-Pichard A, Mallet V, Nalpas B,
Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H and Pol S:
FIB-4: An inexpensive and accurate marker of fibrosis in HCV
infection. comparison with liver biopsy and fibrotest. Hepatology.
46:32–36. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shah AG, Lydecker A, Murray K, Tetri BN,
Contos MJ and Sanyal AJ: Nash Clinical Research Network: Comparison
of noninvasive markers of fibrosis in patients with nonalcoholic
fatty liver disease. Clin Gastroenterol Hepatol. 7:1104–1112.
2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care 34 (Suppl
1): S62-S69, 2011.
|
|
30
|
Beck JD, Slade G and Offenbacher S: Oral
disease, cardiovascular disease and systemic inflammation.
Periodontol 2000. 23:110–120. 2000.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Beukers NG, van der Heijden GJ, van Wijk
AJ and Loos BG: Periodontitis is an independent risk indicator for
atherosclerotic cardiovascular diseases among 60 174 participants
in a large dental school in the Netherlands. J Epidemiol Community
Health. 71:37–42. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mealey BL and Oates TW: American Academy
of Periodontology: Diabetes mellitus and periodontal diseases. J
Periodontol. 77:1289–1303. 2006.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Whitmore SE and Lamont RJ: Oral bacteria
and cancer. PLoS Pathog. 10(e1003933)2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Uppal A, Uppal S, Pinto A, Dutta M,
Shrivatsa S, Dandolu V and Mupparapu M: The effectiveness of
periodontal disease treatment during pregnancy in reducing the risk
of experiencing preterm birth and low birth weight: A
meta-analysis. J Am Dent Assoc. 141:1423–1434. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Scannapieco FA and Ho AW: Potential
associations between chronic respiratory disease and periodontal
disease: Analysis of National Health and Nutrition Examination
Survey III. J Periodontol. 72:50–56. 2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Sparks Stein P, Steffen MJ, Smith C, Jicha
G, Ebersole JL, Abner E and Dawson D III: Serum antibodies to
periodontal pathogens are a risk factor for Alzheimer's disease.
Alzheimers Dement. 8:196–203. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Novacek G, Plachetzky U, Pötzi R, Lentner
S, Slavicek R, Gangl A and Ferenci P: Dental and periodontal
disease in patients with cirrhosis - role of etiology of liver
disease. J Hepatol. 22:576–582. 1995.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Movin S: Relationship between periodontal
disease and cirrhosis of the liver in humans. J Clin Periodontol.
8:450–458. 1981.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Funatsu K, Yamada M, Kawishima Y, Nishida
J, Ueno M, Ebihara Y, Mizuno Y, Oda M and Tsuchiya M:
Microcirculatory disturbances of oral mucosa and periodontal
disease in patients with liver cirrhosis. J Gastroenterol Hepatol.
4 (Suppl 1):99–102. 1989.PubMed/NCBI
|
|
40
|
Grønkjær LL: Periodontal disease and liver
cirrhosis: A systematic review. SAGE Open Med.
3(2050312115601122)2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Farias BC, Souza PR, Ferreira B, Melo RS,
Machado FB, Gusmão ES and Cimões R: Occurrence of periodontal
pathogens among patients with chronic periodontitis. Braz J
Microbiol. 43:909–916. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Katz J, Onate MD, Pauley KM, Bhattacharyya
I and Cha S: Presence of Porphyromonas gingivalis in
gingival squamous cell carcinoma. Int J Oral Sci. 3:209–215.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ahn J, Segers S and Hayes RB: Periodontal
disease, Porphyromonas gingivalis serum antibody levels and
orodigestive cancer mortality. Carcinogenesis. 33:1055–1058.
2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Michaud DS, Izard J, Wilhelm-Benartzi CS,
You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M,
Fedirko V, et al: Plasma antibodies to oral bacteria and risk of
pancreatic cancer in a large European prospective cohort study.
Gut. 62:1764–1770. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Matsushita K, Hamaguchi M, Hashimoto M,
Yamazaki M, Yamazaki T, Asai K, Yamori M, Bessho K, Toda H,
Hasegawa G, et al: The novel association between red complex of
oral microbe and body mass index in healthy Japanese: A population
based cross-sectional study. J Clin Biochem Nutr. 57:135–139.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chigasaki O, Takeuchi Y, Aoki A, Sasaki Y,
Mizutani K, Aoyama N, Ikeda Y, Gokyu M, Umeda M, Ishikawa I, et al:
A cross-sectional study on the periodontal status and prevalence of
red complex periodontal pathogens in a Japanese population. J Oral
Sci. 60:293–303. 2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hamada S, Fujiwara T, Morishima S,
Takahashi I, Nakagawa I, Kimura S and Ogawa T: Molecular and
immunological characterization of the fimbriae of Porphyromonas
gingivalis. Microbiol Immunol. 38:921–930. 1994.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Amano A, Nakagawa I, Kataoka K, Morisaki I
and Hamada S: Distribution of Porphyromonas gingivalis
strains with fimA genotypes in periodontitis patients. J Clin
Microbiol. 37:1426–1430. 1999.PubMed/NCBI
|
|
49
|
Gustot T, Durand F, Lebrec D, Vincent JL
and Moreau R: Severe sepsis in cirrhosis. Hepatology. 50:2022–2033.
2009.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Thalheimer U, Triantos CK, Samonakis DN,
Patch D and Burroughs AK: Infection, coagulation, and variceal
bleeding in cirrhosis. Gut. 54:556–563. 2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ashare A, Stanford C, Hancock P, Stark D,
Lilli K, Birrer E, Nymon A, Doerschug KC and Hunninghake GW:
Chronic liver disease impairs bacterial clearance in a human model
of induced bacteremia. Clin Transl Sci. 2:199–205. 2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Van Dyke TE and van Winkelhoff AJ:
Infection and inflammatory mechanisms. J Periodontol. 84 (Suppl
4):S1–S7. 2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Scannapieco FA: The oral microbiome: Its
role in health and in oral and systemic infections. Clin Mic News.
35:163–169. 2013. View Article : Google Scholar
|
|
54
|
Qin N, Yang F, Li A, Prifti E, Chen Y,
Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al: Alterations of
the human gut microbiome in liver cirrhosis. Nature. 513:59–64.
2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Nakajima M, Arimatsu K, Kato T, Matsuda Y,
Minagawa T, Takahashi N, Ohno H and Yamazaki K: Oral administration
of P. gingivalis induces cysbiosis of gut microbiota and
impaired barrier function leading to dissemination of
enterobacteria to the liver. PLoS One. 10(e0134234)2015.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Nishimura F and Murayama Y: Periodontal
inflammation and insulin resistance--lessons from obesity. J Dent
Res. 80:1690–1694. 2001.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Nagao Y, Hanada S, Shishido S, Ide T,
Kumashiro R, Ueno T and Sata M: Incidence of Sjögren's syndrome in
Japanese patients with hepatitis C virus infection. J Gastroenterol
Hepatol. 18:258–266. 2003.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Tatsuoka S: Issue record of ‘Research to
understand the actual situation of prejudice and discrimination
against hepatitis virus infected people, and to prepare guidelines
for prevention of the damage’ by Health, Labour and Welfare
Sciences Research Grants. 2011-2013.(In Japanese).
|
